Caris Life Sciences, Inc. (CAI)

NASDAQ: CAI · Real-Time Price · USD

36.35

-0.45 (-1.22%)

At close: Sep 4, 2025, 4:00 PM

36.83

+0.48 (1.32%)

After-hours: Sep 4, 2025, 6:45 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Molecular Profiling Services	349.12M	Log In
Molecular Profiling Services Growth	25.24%	Log In
Pharma Research and Development Services	63.15M	Log In
Pharma Research and Development Services Growth	130.62%	Log In

Revenue by Geography

Fiscal year is January - December.